ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
$14.44
arrow_downward
-0.21%(-0.030) 1D
$14.44
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 1, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALPMY...
Open
$15.16
High
$15.16
Low
$14.41
Mkt. cap
4.18T
Avg. vol.
102.43K
Volume
130.31K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.14
Shares outstanding
1.81B
No. of employees
14K
Open
$15.16
High
$15.16
Low
$14.41
Mkt. cap
4.18T
Avg. vol.
102.43K
Volume
130.31K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.14
Shares outstanding
1.81B
No. of employees
14K
News stories
From web sources and news partners
Simply Wall Street
·
12 hours ago
Did Phase 3 Trial Start Just Shift Astellas Pharma's (TSE:4503) Investment Narrative?
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com